+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Hemophilia Treatment Market - Product Thumbnail Image

Hemophilia Treatment Market

  • Report
  • February 2022
  • 312 Pages
From
From
Global Rare Hemophilia Factors Market 2022-2026 - Product Thumbnail Image

Global Rare Hemophilia Factors Market 2022-2026

  • Report
  • June 2022
  • 120 Pages
From
From
Hemophilia Market 2020-2026 - Product Thumbnail Image

Hemophilia Market 2020-2026

  • Report
  • August 2020
From
From
From
From
From
Loading Indicator